ARYA Sciences Acquisition Valuation
| ARYDDelisted Stock | USD 5.20 0.33 5.97% |
At this time, the firm appears to be overvalued. ARYA Sciences Acquisition shows a prevailing Real Value of $4.94 per share. The current price of the firm is $5.2. Our model approximates the value of ARYA Sciences Acquisition from analyzing the firm fundamentals such as return on asset of -0.0728, and Shares Outstanding of 3.8 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ARYA Sciences' price fluctuation is very steady at this time. Calculation of the real value of ARYA Sciences Acquisition is based on 3 months time horizon. Increasing ARYA Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the ARYA stock is determined by what a typical buyer is willing to pay for full or partial control of ARYA Sciences Acquisition. Since ARYA Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ARYA Stock. However, ARYA Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.2 | Real 4.94 | Hype 5.2 | Naive 7.17 |
The real value of ARYA Stock, also known as its intrinsic value, is the underlying worth of ARYA Sciences Acquisition Company, which is reflected in its stock price. It is based on ARYA Sciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ARYA Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ARYA Sciences Acquisition helps investors to forecast how ARYA stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ARYA Sciences more accurately as focusing exclusively on ARYA Sciences' fundamentals will not take into account other important factors: ARYA Sciences Total Value Analysis
ARYA Sciences Acquisition is presently anticipated to have valuation of 42.25 M with market capitalization of 50.04 M, debt of 2.17 M, and cash on hands of 49.53 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the ARYA Sciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
42.25 M | 50.04 M | 2.17 M | 49.53 K |
ARYA Sciences Asset Utilization
One of the ways to look at asset utilization of ARYA is to check how much profit was generated for every dollar of assets it reports. ARYA Sciences Acquisition shows a negative utilization of assets of -0.0728 percent, losing $7.28E-4 for each dollar of assets held by the firm. Ineffective asset utilization signifies that the company is being less competent with each dollar of assets it shows. Put another way, asset utilization of ARYA Sciences Acquisition shows how unsuccessful it operates for each dollar spent on its assets.ARYA Sciences Ownership Allocation
Over half of ARYA Sciences' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions.ARYA Sciences Profitability Analysis
Net Loss for the year was (2.13 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ARYA Sciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ARYA Sciences and how it compares across the competition.
About ARYA Sciences Valuation
The delisted stock valuation mechanism determines ARYA Sciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of ARYA Sciences. We calculate exposure to ARYA Sciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ARYA Sciences's related companies.ARYA Sciences Acquisition Corp IV does not have significant operations. The company was incorporated in 2020 and is based in New York, New York. Arya Sciences operates under Shell Companies classification in the United States and is traded on NASDAQ Exchange.
ARYA Sciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as ARYA Sciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 9.8 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in ARYA Stock
If you are still planning to invest in ARYA Sciences Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ARYA Sciences' history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |